CHCT,HROW Stock Price and Quote

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change +0.27
Percentage change 1.58	%

Peers: WELL VTR HR DOC OHI MPW GMRE LTC EPRT SBRA

| Held by: VNQ VTI KBWY IWM DIV VXF SMDV IWN SCHH VTWO

Index	RUT	P/E	-	EPS (ttm)	-0.31	Insider Own	5.57%	Shs Outstand	28.34M	Perf Week	3.34%
Market Cap	491.09M	Forward P/E	38.51	EPS next Y	0.45	Insider Trans	1.40%	Shs Float	26.76M	Perf Month	3.09%
Enterprise Value	990.99M	PEG	-	EPS next Q	-0.13	Inst Own	81.95%	Short Float	3.13%	Perf Quarter	13.71%
Income	-8.15M	P/S	4.21	EPS this Y	143.48%	Inst Trans	-1.55%	Short Ratio	3.88	Perf Half Y	-9.74%
Sales	116.53M	P/B	1.06	EPS next Y	350.00%	ROA	-0.83%	Short Interest	0.84M	Perf YTD	-9.79%
Book/sh	16.28	P/C	216.34	EPS next 5Y	-	ROE	-1.67%	52W High	27.62 -37.26%	Perf Year	-27.58%
Cash/sh	0.08	P/FCF	13.48	EPS past 3/5Y	- -	ROIC	-0.85%	52W Low	14.76 17.45%	Perf 3Y	-51.46%
Dividend Est.	1.89 (10.91%)	EV/EBITDA	13.43	Sales past 3/5Y	8.53% 13.73%	Gross Margin	42.85%	Volatility	2.17% 2.47%	Perf 5Y	-58.35%
Dividend TTM	1.86 (10.76%)	EV/Sales	8.50	EPS Y/Y TTM	-149.80%	Oper. Margin	26.03%	ATR (14)	0.42	Perf 10Y	-9.36%
Dividend Ex-Date	May 09, 2025	Quick Ratio	4.31	Sales Y/Y TTM	1.33%	Profit Margin	-6.99%	RSI (14)	58.53	Recom	1.80
Dividend Gr. 3/5Y	2.08% 2.20%	Current Ratio	4.31	EPS Q/Q	-72.82%	SMA20	2.66%	Beta	0.66	Target Price	20.50
Payout	-	Debt/Eq	1.09	Sales Q/Q	2.54%	SMA50	3.95%	Rel Volume	0.62	Prev Close	17.06
Employees	36	LT Debt/Eq	1.09	Earnings	Jul 29 AMC	SMA200	-2.88%	Avg Volume	215.73K	Price	17.33
IPO	May 21, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-57.14% 0.51%	Trades		Volume	135,863	Change	1.58%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-16-24	Upgrade	Evercore ISI	Underperform → In-line	$21 → $18
May-01-24	Downgrade	Piper Sandler	Overweight → Neutral	$36 → $26
Nov-02-23	Downgrade	Evercore ISI	Outperform → In-line	$36 → $32
Sep-22-23	Downgrade	Robert W. Baird	Outperform → Neutral	$43 → $33
Jan-13-23	Upgrade	Janney	Neutral → Buy	$44
Nov-25-20	Upgrade	Evercore ISI	In-line → Outperform
Nov-05-20	Reiterated	B. Riley Securities	Neutral	$47 → $49
Sep-30-20	Resumed	Robert W. Baird	Outperform	$51
Sep-09-20	Initiated	Colliers Securities	Buy	$52
Jun-08-20	Downgrade	Evercore ISI	Outperform → In-line	$43
May-07-20	Downgrade	B. Riley FBR	Buy → Neutral	$40
Mar-30-20	Upgrade	DA Davidson	Neutral → Buy	$55 → $40
Mar-20-20	Upgrade	B. Riley FBR	Neutral → Buy	$47 → $40
Nov-18-19	Upgrade	Sandler O'Neill	Hold → Buy
Jul-10-19	Downgrade	Janney	Buy → Neutral
Apr-23-19	Initiated	Berenberg	Buy	$41
Apr-10-19	Initiated	Robert W. Baird	Outperform
Apr-05-19	Downgrade	Sandler O'Neill	Buy → Hold
Mar-28-19	Initiated	DA Davidson	Neutral
Nov-12-18	Reiterated	B. Riley FBR	Neutral	$32 → $31

Show Previous Ratings

Jul-01-25 05:40PM	Community Healthcare Trust Announces Second Quarter Earnings Release Date And Conference Call (PR Newswire)
Jun-11-25 06:09PM	Community Healthcare Trust Releases 2024 Corporate Sustainability Report (PR Newswire)
Jun-04-25 10:31AM	Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks (Zacks)
May-06-25 04:30PM	Community Healthcare Trust Incorporated Announces Key Leadership Change (PR Newswire)
07:21AM	Community Healthcare Trust Incorporated (CHCT): A Top Dividend Challenger in 2025 (Insider Monkey)
09:54AM	Loading…
May-03-25 09:54AM	Community Healthcare Trust: Evaluating Upside Potential For A Strategic Buyer (Seeking Alpha)
01:26AM	Dividend Champion, Contender, And Challenger Highlights: Week Of May 4 (Seeking Alpha)
May-01-25 03:14AM	Community Healthcare Trust Inc (CHCT) Q1 2025 Earnings Call Highlights: Steady Growth Amid ... (GuruFocus.com)
Apr-30-25 01:56PM	Community Healthcare Trust Incorporated (CHCT) Q1 2025 Earnings Call Transcript (Seeking Alpha) +5.04%
Apr-29-25 07:00PM	Community Healthcare Trust (CHCT) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:45PM	Community Healthcare Trust (CHCT) Surpasses Q1 FFO and Revenue Estimates (Zacks)
04:43PM	Community Healthcare Trust: Q1 Earnings Snapshot (Associated Press Finance)
04:30PM	Community Healthcare Trust Announces Results for the Three Months Ended March 31, 2025 (PR Newswire)
Apr-24-25 05:44PM	Community Healthcare Trust Incorporated Announces Increased First Quarter Dividend (PR Newswire)
Apr-11-25 10:01PM	How Much Would It Take To Earn $100 A Month From Community Healthcare Stock (Benzinga)
10:27AM	Loading…
Apr-10-25 10:27AM	First Industrial Realty Trust (FR) Moves 7.6% Higher: Will This Strength Last? (Zacks) -7.19%
Apr-07-25 07:30AM	Mousetraps: 9 High-Yield REITS With Potentially Unsafe Dividends (Seeking Alpha)
Apr-02-25 06:00PM	Community Healthcare Trust Announces First Quarter Earnings Release Date And Conference Call (PR Newswire)
Feb-20-25 02:09AM	Community Healthcare Trust Inc (CHCT) Q4 2024 Earnings Call Highlights: Navigating Challenges ... (GuruFocus.com)
12:33AM	Q4 2024 Community Healthcare Trust Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-19-25 04:54AM	Community Healthcare Trust Inc (CHCT) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) -6.31%
Feb-18-25 06:30PM	Community Healthcare Trust (CHCT) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:50PM	Community Healthcare Trust (CHCT) Q4 FFO Top Estimates (Zacks)
05:00PM	Community Healthcare Trust: Q4 Earnings Snapshot (Associated Press Finance)
04:30PM	Community Healthcare Trust Announces Results for the Three Months Ended December 31, 2024 (PR Newswire)
02:50AM	Earnings To Watch: Community Healthcare Trust Inc (CHCT) Reports Q4 2024 Result (GuruFocus.com)
Feb-13-25 05:42PM	Community Healthcare Trust Incorporated Announces Increased Fourth Quarter Dividend (PR Newswire)
Jan-16-25 05:15PM	Community Healthcare Trust Announces Fourth Quarter Earnings Release Date And Conference Call (PR Newswire)
Dec-18-24 09:40AM	Should Value Investors Buy Community Healthcare Trust (CHCT) Stock? (Zacks)
Dec-13-24 08:30PM	KBW Announces Index Rebalancing for Fourth-Quarter 2024 (GlobeNewswire)
02:21PM	Loading…
Dec-02-24 02:21PM	Are Investors Undervaluing Community Healthcare Trust (CHCT) Right Now? (Zacks)
Nov-15-24 09:40AM	Is Community Healthcare Trust (CHCT) Stock Undervalued Right Now? (Zacks)
Oct-31-24 04:08AM	Q3 2024 Community Healthcare Trust Inc Earnings Call (Thomson Reuters StreetEvents)
04:06AM	3 Scary High-Yield Dividend Stocks That Income Investors Should Avoid Right Now (Motley Fool)
03:13AM	Community Healthcare Trust Inc (CHCT) Q3 2024 Earnings Call Highlights: Revenue Growth and ... (GuruFocus.com)
Oct-29-24 06:30PM	Community Healthcare Trust (CHCT) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) +6.70%
05:45PM	Community Healthcare Trust (CHCT) Surpasses Q3 FFO and Revenue Estimates (Zacks)
04:43PM	Community Healthcare Trust: Q3 Earnings Snapshot (Associated Press Finance)
04:30PM	Community Healthcare Trust Announces Results for the Three Months Ended September 30, 2024 (PR Newswire)
09:15AM	Community Healthcare Trust Inc (CHCT) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
09:00AM	Long-Term Rewards: 3 REITs That Just Increased Dividends and Extended Their Streaks (ADC, GTY, CHCT) (Benzinga)
Oct-28-24 09:07AM	Community Healthcare Trust Inc (CHCT) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-24-24 06:00PM	Community Healthcare Trust Incorporated Announces Increased Third Quarter Dividend (PR Newswire) +5.13%
Oct-20-24 02:39PM	Community Healthcare Trust Incorporated (CHCT): Among the Worst Performing REITs in 2024 (Insider Monkey)
Oct-17-24 03:08PM	State Street Corp's Strategic Reduction in Community Healthcare Trust Inc Holdings (GuruFocus.com)
Oct-16-24 04:30PM	Community Healthcare Trust Incorporated Announces Upsizing and Maturity Extension of $400 Million Senior Unsecured Line of Credit (PR Newswire)
Oct-09-24 03:34PM	Community Healthcare Trust Inc (CHCT) Q2 2024 Earnings Call Highlights: Navigating Revenue ... (GuruFocus.com)
05:29AM	Got $5,000? Supercharge Your Passive Income With These 5 Ultra-High-Yield, High-Risk Dividend Stocks. (Motley Fool)
Oct-04-24 06:15AM	Is This 10%-Yielding Dividend Stock's Magnificent Growth Streak About to Come to an Abrupt End? (Motley Fool)
Oct-01-24 06:19PM	Community Healthcare Trust Announces Third Quarter Earnings Release Date And Conference Call (PR Newswire)
Sep-11-24 01:17PM	Director Van Horn R. Lawrence Acquires 10,000 Shares of Community Healthcare Trust Inc (CHCT) (GuruFocus.com)
Sep-06-24 06:43PM	Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Aug-06-24 11:30PM	Insider Buying: CEO David Dupuy Acquires Shares of Community Healthcare Trust Inc (GuruFocus.com)
Aug-05-24 03:00PM	5 REITs Get Downgrades This Week (Benzinga)
Jul-30-24 07:00PM	Community Healthcare Trust (CHCT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -20.90%
06:05PM	Community Healthcare Trust (CHCT) Lags Q2 FFO and Revenue Estimates (Zacks)
05:03PM	Community Healthcare Trust: Q2 Earnings Snapshot (Associated Press Finance)
04:30PM	Community Healthcare Trust Announces Results for the Three Months Ended June 30, 2024 (PR Newswire)
Jul-25-24 07:51PM	Community Healthcare Trust Incorporated Announces Increased Second Quarter Dividend (PR Newswire)
Jul-03-24 09:00AM	Community Healthcare Trust Announces Second Quarter Earnings Release Date And Conference Call (PR Newswire)
May-21-24 05:21PM	Community Healthcare Trust Releases Inaugural Corporate Sustainability Report (PR Newswire)
May-02-24 08:46AM	Community Healthcare Trust Incorporated (NYSE:CHCT) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:08AM	Piper Sandler Downgrades Community Healthcare Trust to Neutral from Overweight, Cuts Price Target to $26 From $36 (MT Newswires)
03:22AM	Community Healthcare Trust Inc (CHCT) (Q1 2024) Earnings Call Transcript Highlights: Robust ... (GuruFocus.com)
12:59AM	Q1 2024 Community Healthcare Trust Inc Earnings Call (Thomson Reuters StreetEvents)
Apr-30-24 09:53PM	CHCT Stock Earnings: Community Healthcare Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) -5.47%
07:00PM	Compared to Estimates, Community Healthcare Trust (CHCT) Q1 Earnings: A Look at Key Metrics (Zacks)
05:57PM	Community Healthcare Trust Inc (CHCT) Q1 Earnings: Misses EPS Estimates, Outperforms on Revenue (GuruFocus.com)
05:45PM	Community Healthcare Trust (CHCT) Lags Q1 FFO and Revenue Estimates (Zacks)
04:43PM	Community Healthcare Trust: Q1 Earnings Snapshot (Associated Press Finance)
04:30PM	Community Healthcare Trust Announces Results for the Three Months Ended March 31, 2024 (PR Newswire)
Apr-28-24 09:57AM	10 Stocks with Latest Dividend Increases (Insider Monkey)
Apr-25-24 05:43PM	Community Healthcare Trust Incorporated Announces Increased First Quarter Dividend (PR Newswire)
Apr-05-24 04:45PM	Community Healthcare Trust Announces First Quarter Earnings Release Date And Conference Call (PR Newswire)
Feb-15-24 08:45AM	Community Healthcare Trust Incorporated (NYSE:CHCT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-13-24 07:00PM	Community Healthcare Trust (CHCT) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
06:00PM	Community Healthcare Trust (CHCT) Q4 FFO and Revenues Lag Estimates (Zacks)
05:34PM	Community Healthcare Trust Inc Reports Solid Q4 Earnings Amidst Strategic Acquisitions (GuruFocus.com)
05:06PM	Community Healthcare Trust: Q4 Earnings Snapshot (Associated Press Finance)
04:45PM	Community Healthcare Trust Announces Results for the Three Months Ended December 31, 2023 (PR Newswire)
Feb-12-24 12:39PM	3 REITs That Just Increased Dividends (Benzinga)
Feb-08-24 07:13PM	Community Healthcare Trust Incorporated Announces Increased Fourth Quarter Dividend (PR Newswire)
Jan-23-24 04:45PM	Community Healthcare Trust Announces Fourth Quarter Earnings Release Date And Conference Call (PR Newswire)
Nov-02-23 09:29AM	Community Healthcare Trust Incorporated (NYSE:CHCT) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-01-23 11:48PM	Q3 2023 Community Healthcare Trust Inc Earnings Call (Thomson Reuters StreetEvents)
Oct-31-23 07:30PM	Community Healthcare Trust (CHCT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:16PM	Community Healthcare Trust Inc (CHCT) Reports Q3 2023 Earnings, Net Income of $3.5 Million (GuruFocus.com)
06:15PM	Community Healthcare Trust (CHCT) Q3 FFO Meet Estimates (Zacks)
05:09PM	Community Healthcare Trust: Q3 Earnings Snapshot (Associated Press Finance)
04:30PM	Community Healthcare Trust Announces Results for the Three Months Ended September 30, 2023 (PR Newswire)
Oct-26-23 07:30PM	Community Healthcare Trust Incorporated Announces Increased Third Quarter Dividend (PR Newswire)
06:08AM	2 Ultra-High-Yield Real Estate Stocks to Buy Hand Over Fist and 1 to Avoid (Motley Fool)
Oct-24-23 05:30PM	EastGroup Properties (EGP) Q3 FFO and Revenues Beat Estimates (Zacks)
Oct-04-23 07:19PM	Community Healthcare Trust Announces Third Quarter Earnings Release Date And Conference Call (PR Newswire)
Sep-22-23 09:38AM	Wayfair upgraded, Deere downgraded: Wall Street's top analyst calls (The Fly)
Aug-05-23 03:35PM	Community Healthcare Trust Incorporated (NYSE:CHCT) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-04-23 04:24PM	REITs Beating And Meeting FFO Estimates Yet Missing On Revenues: Is This A Sign Of Things To Come? (Benzinga)
Aug-03-23 04:19AM	Q2 2023 Community Healthcare Trust Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-01-23 06:30PM	Compared to Estimates, Community Healthcare Trust (CHCT) Q2 Earnings: A Look at Key Metrics (Zacks)
06:05PM	Community Healthcare Trust (CHCT) Q2 FFO Top Estimates (Zacks)

Community Healthcare Trust, Inc. is a healthcare real estate company, which engages in acquiring real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers. The company was founded by Timothy G. Wallace, William Page Barnes, Leigh Ann Stach, Ron Hart, Bill Davis, Stephen M. Harrison, Mike Willman, and Jim Short on March 28, 2014 and is headquartered in Franklin, TN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Van Horn R. Lawrence	Director	May 28 '25	Buy	16.37	11,815	193,412	88,502	May 30 05:33 PM
Dupuy David H.	CEO and President	May 13 '25	Buy	16.23	10,000	162,300	458,500	May 14 04:15 PM
Cotman Cathrine	Director	Apr 30 '25	Buy	17.10	3,000	51,300	23,861	May 02 04:19 PM
Cotman Cathrine	Director	Apr 30 '25	Sale	17.09	3,000	51,270	20,861	May 02 04:19 PM
Van Horn R. Lawrence	Director	Sep 09 '24	Buy	16.13	10,000	161,300	62,230	Sep 10 04:15 PM
Cotman Cathrine	Director	Aug 13 '24	Buy	17.72	2,000	35,440	20,861	Aug 14 04:16 PM
Hensley Robert Z	Director	Aug 05 '24	Buy	19.50	6,500	126,750	70,670	Aug 06 06:42 PM
Van Horn R. Lawrence	Director	Aug 05 '24	Buy	19.42	2,500	48,550	52,230	Aug 06 05:06 PM
Dupuy David H.	CEO and President	Aug 05 '24	Buy	19.48	10,000	194,800	363,565	Aug 06 05:04 PM

Dollar change +0.69
Percentage change 1.98	%

Peers: OCUL EYPT PRPH AKTX ALDX EDIT QURE TTOO CRSP BNGO

| Held by: IWM VTI VXF IWO SCHA VTWO IHE XPH VHT DWAS

Index	RUT	P/E	-	EPS (ttm)	-0.61	Insider Own	16.01%	Shs Outstand	35.65M	Perf Week	13.58%
Market Cap	1.31B	Forward P/E	23.27	EPS next Y	1.53	Insider Trans	-1.43%	Shs Float	30.83M	Perf Month	12.69%
Enterprise Value	1.47B	PEG	-	EPS next Q	0.01	Inst Own	56.48%	Short Float	13.41%	Perf Quarter	51.74%
Income	-21.70M	P/S	6.14	EPS this Y	130.00%	Inst Trans	-0.28%	Short Ratio	9.53	Perf Half Y	-1.47%
Sales	212.86M	P/B	22.50	EPS next Y	941.16%	ROA	-6.58%	Short Interest	4.13M	Perf YTD	6.17%
Book/sh	1.58	P/C	19.59	EPS next 5Y	-	ROE	-37.23%	52W High	59.23 -39.86%	Perf Year	54.47%
Cash/sh	1.82	P/FCF	3112.48	EPS past 3/5Y	10.79% -	ROIC	-12.22%	52W Low	20.85 70.84%	Perf 3Y	394.04%
Dividend Est.	-	EV/EBITDA	69.88	Sales past 3/5Y	40.17% 31.29%	Gross Margin	74.53%	Volatility	5.88% 4.78%	Perf 5Y	594.35%
Dividend TTM	-	EV/Sales	6.91	EPS Y/Y TTM	33.18%	Oper. Margin	2.24%	ATR (14)	1.66	Perf 10Y	333.33%
Dividend Ex-Date	-	Quick Ratio	0.85	Sales Y/Y TTM	53.49%	Profit Margin	-10.19%	RSI (14)	72.07	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.91	EPS Q/Q	-29.79%	SMA20	12.99%	Beta	0.41	Target Price	59.27
Payout	-	Debt/Eq	4.07	Sales Q/Q	38.29%	SMA50	22.96%	Rel Volume	1.62	Prev Close	34.93
Employees	382	LT Debt/Eq	2.14	Earnings	May 08 AMC	SMA200	4.66%	Avg Volume	433.66K	Price	35.62
IPO	Apr 24, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	-986.96% -16.08%	Trades		Volume	694,658	Change	1.98%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-11-25	Initiated	Cantor Fitzgerald	Overweight	$76
Jun-12-25	Initiated	BTIG Research	Buy	$62
Jun-10-25	Initiated	William Blair	Outperform
Feb-06-25	Initiated	H.C. Wainwright	Buy	$57
Dec-04-24	Reiterated	B. Riley Securities	Buy	$73 → $69
Apr-11-24	Initiated	Craig Hallum	Buy	$24
Sep-08-22	Resumed	B. Riley Securities	Buy	$17
Oct-14-21	Resumed	B. Riley Securities	Buy	$16
Sep-24-21	Initiated	Aegis Capital	Buy	$15
Jul-02-21	Initiated	Ladenburg Thalmann	Buy	$14.25

Jul-14-25 10:01AM	Harrow (HROW) Stock Jumps 11.4%: Will It Continue to Soar? (Zacks)
Jul-12-25 09:40AM	CoreWeave initiated, Texas Instruments upgraded: Wall Streets top analyst calls (TipRanks)
Jul-11-25 09:38AM	CoreWeave initiated, Texas Instruments upgraded: Wall Street's top analyst calls (The Fly) +11.35%
Jul-06-25 04:15AM	William Blair Initiates Coverage of Harrow (HROW) With an Outperform Rating (Insider Monkey)
Jul-02-25 09:00AM	Are Options Traders Betting on a Big Move in Harrow Stock? (Zacks)
07:00AM	Loading…
Jun-18-25 07:00AM	Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications (Business Wire)
Jun-09-25 07:00AM	Harrow Acquires U.S. Commercial Rights to BYQLOVI (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals (Business Wire)
May-14-25 10:07AM	Jim Cramer on Harrow, Inc. (HROW) - "Eye Care's a Good Biz - If It Makes Money, Don't Walk Away Pre-Breakout" (Insider Monkey)
07:00AM	Harrow to Present at Two Investor Conferences in May (Business Wire)
May-10-25 03:03AM	Harrow Inc (HROW) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... (GuruFocus.com)
May-08-25 05:10PM	Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:01PM	Harrow Announces First-Quarter 2025 Financial Results (Business Wire)
09:32AM	Harrow Inc (HROW) Q1 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
May-07-25 10:28AM	What To Expect From Harrow Inc (HROW) Q1 2025 Earnings (GuruFocus.com)
May-05-25 07:00AM	Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025 (Business Wire)
07:35AM	Loading…
Apr-30-25 07:35AM	United Therapeutics (UTHR) Q1 Earnings and Revenues Top Estimates (Zacks)
Apr-29-25 07:35AM	What Recession? I'm Swimming In Dividends (Seeking Alpha)
Apr-24-25 10:00AM	NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES LAUNCH OF AUTHORIZED GENERIC OF Maxitrol (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension) (PR Newswire) +5.20%
Apr-21-25 04:26PM	Harrow Inc (HROW) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Apr-10-25 07:00AM	Harrow Expands VEVYE Access for All Program to ImprimisRxs Klarity-C Patients (Business Wire) -5.76%
Mar-29-25 04:30PM	Harrow: When Cheaper Doesn't Mean Attractive (Rating Upgrade) (Seeking Alpha)
03:01PM	Harrow Inc (HROW) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Initiatives (GuruFocus.com)
Mar-28-25 02:00PM	Harrow, Inc. (HROW) Q4 2024 Earnings Conference Call (Seeking Alpha) -5.96%
01:39PM	Harrow Inc.: Roll The Dice For Strong Upside Prospects As Earnings Ramp (Seeking Alpha)
Mar-27-25 06:45PM	Harrow (HROW) Q4 Earnings and Revenues Top Estimates (Zacks)
04:01PM	Harrow Announces Fourth-Quarter and Year-End 2024 Audited Financial Results (Business Wire)
10:45AM	Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025 (Business Wire)
Mar-24-25 07:00AM	Harrow Announces Transitional Pass-Through Reimbursement Status for TRIESENCE (Triamcinolone Acetonide Injectable Suspension) 40 mg/mL (Business Wire) +5.60%
Mar-21-25 10:56PM	What To Expect From Harrow Inc (HROW) Q4 2024 Earnings (GuruFocus.com)
Mar-19-25 05:18PM	Harrow: A Name I Am Accumulating (SeekingAlpha)
04:01PM	Loading…
Mar-17-25 04:01PM	Harrow Provides Fourth Quarter and Year-End 2024 Unaudited Preliminary Financial Results and 2025 Revenue Guidance (Business Wire) +15.69%
07:00AM	Harrow Launches VEVYE Access for All (Business Wire)
Mar-11-25 07:00AM	Harrow Executes Five-Year Strategic Supply and Development Agreement for TRIESENCE (Business Wire)
Mar-03-25 07:15AM	Harrow to Report Fourth Quarter and Year-End 2024 Financial Results After Market Close on March 17, 2025 (Business Wire) -8.73%
Feb-07-25 09:40AM	Reddit initiated, Cigna downgraded: Wall Streets top analyst calls (TipRanks)
Jan-27-25 07:30AM	Harrow Partners with Cencora to Launch Harrow Cares Program, Making IHEEZO and TRIESENCE More Accessible and Affordable for Retina Specialists and Their Patients (Business Wire)
Jan-07-25 07:00AM	Harrow Appoints Amir H. Shojaei as Chief Scientific Officer (Business Wire)
Nov-21-24 07:00AM	Harrows ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc. (Business Wire)
Nov-20-24 07:00AM	Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery (Business Wire) +6.90%
Nov-15-24 07:00AM	Harrow Announces Participation in Upcoming Investor Conferences (Business Wire) -8.98%
02:06AM	Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... (GuruFocus.com)
Nov-13-24 04:34PM	Harrow Announces Third Quarter 2024 Financial Results (Business Wire) -17.26%
07:16AM	Harrow Inc (HROW) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
07:00AM	Harrow Launches Access and Affordability Program with Price Reductions for Branded Products (Business Wire)
Nov-12-24 07:00AM	Harrow Announces Market Access Wins for VEVYE (Business Wire)
Nov-07-24 07:00AM	Harrow Partners with Asembia to Enhance Provider and Patient Experience Through Nationwide Digital Services and Hub Support for Harrows Branded Eyecare Products (Business Wire)
Oct-31-24 07:00AM	Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024 (Business Wire)
Oct-10-24 07:00AM	Melt Pharmaceuticals Announces Dosing of Last Patient in Pivotal Phase 3 Study of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery (Business Wire)
Oct-03-24 07:00AM	Harrow Relaunches TRIESENCE (Business Wire) +8.44%
Oct-02-24 11:10AM	Harrow, Inc. (HROW): A Bull Case Theory (Insider Monkey)
Sep-25-24 12:02PM	Harrow Announces Nashville Expansion (Business Wire)
Sep-03-24 07:00AM	Harrow to Present at Three Investor Conferences in September in New York (Business Wire)
Aug-07-24 04:01PM	Harrow Announces Second Quarter 2024 Financial Results (Business Wire) +54.32%
Jul-25-24 07:00AM	Harrow To Report Second Quarter 2024 Financial Results After Market Close on August 7, 2024 (Business Wire)
Jul-12-24 07:00AM	Harrow to Attend 2024 ASRS Annual Meeting (Business Wire)
Jul-09-24 07:00AM	Harrow Enters into 340B Prime Vendor Program Contract with Apexus for IHEEZO and Other Key Harrow Products (Business Wire)
Jul-02-24 11:52AM	HROW Stock Earnings: Harrow Beats EPS, Beats Revenue for Q2 2023 (InvestorPlace)
Jun-20-24 07:00AM	Harrow Provides TRIESENCE Relaunch Update (Business Wire) +12.92%
Jun-07-24 06:30AM	The Top 7 Growth Stocks to Buy and Hold Until 2030 (InvestorPlace)
Jun-06-24 08:00AM	Melt Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 Program of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery (Business Wire)
Jun-05-24 07:00AM	Harrow Announces 52-Week Data from VEVYE ESSENCE-2 Open-Label Extension Study (Business Wire)
May-15-24 07:00AM	Harrow to Present at Two Investor Conferences in May (Business Wire)
May-13-24 08:55PM	HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) +34.55%
04:25PM	Harrow Health Q1 Core Net Loss Widens, Revenue Increases -- Shares Rise After-Hours (MT Newswires)
04:01PM	Harrow Announces First Quarter 2024 Financial Results (Business Wire)
07:00AM	Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial (Business Wire)
Apr-25-24 07:00AM	Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024 (Business Wire)
Apr-02-24 08:16AM	Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing (Business Wire)
Mar-21-24 09:55AM	Harrow Health, Inc. (NASDAQ:HROW) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-19-24 09:52PM	HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
06:51PM	Harrow Inc (HROW) Reports Substantial Revenue Growth Amidst Net Loss Expansion in 2023 (GuruFocus.com)
05:45PM	Harrow Announces Fourth Quarter and Year-End 2023 Financial Results (Business Wire)
Mar-13-24 06:35AM	Harrow (HROW) Fell on Lowering the Guidance (Insider Monkey)
Mar-05-24 07:00AM	Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024 (Business Wire)
Mar-04-24 08:28PM	11 Best Small Cap Pharma Stocks to Invest In (Insider Monkey)
Feb-21-24 06:47AM	Heres How Harrow (HROW) Weighed on SRK Capitals Performance (Insider Monkey)
Feb-15-24 04:01PM	Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products (Business Wire)
Jan-29-24 07:00AM	Harrow Announces New Appointments to its Board of Directors (Business Wire)
Jan-11-24 07:00AM	Harrow Announces Availability of VEVYE (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease (Business Wire)
Jan-03-24 07:15AM	Melt Pharmaceuticals Provides Corporate Update (Business Wire)
07:00AM	Harrow Partners with Leading Healthcare Market Access Technology Platforms (Business Wire)
Dec-24-23 01:08PM	7 Short-Squeeze Stocks That Are Screaming for Speculation (InvestorPlace)
Nov-29-23 07:00AM	Harrow Completes Transfer of the TRIESENCE New Drug Application (Business Wire)
Nov-20-23 07:00AM	Harrow to Present at Two Investor Conferences in November (Business Wire) +5.58%
Nov-14-23 12:56PM	Harrow Health, Inc. (NASDAQ:HROW) Q3 2023 Earnings Call Transcript (Insider Monkey) -36.01%
Nov-13-23 05:07PM	Harrow Inc (HROW) Reports 50% Revenue Growth in Q3 2023 (GuruFocus.com)
04:01PM	Harrow Announces Third Quarter 2023 Financial Results (Business Wire)
Oct-30-23 08:00AM	Harrow Will Release Third Quarter 2023 Financial Results on November 13, 2023 (Business Wire)
Oct-24-23 07:00AM	Harrow Completes Transfer of NDAs and Launches FLAREX, NATACYN, TOBRADEX ST, VERKAZIA, and ZERVIATE in the U.S. (Business Wire)
Sep-29-23 08:00AM	Harrow Health, Inc. Changes Corporate Name to Harrow, Inc. (Business Wire)
Sep-26-23 08:00AM	Melt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for Its Zydis® Fast-Dissolve Technology for Use in MELT-300 for Needle- and Opioid-Free Procedural Sedation (Business Wire) -5.20%
Sep-21-23 01:03PM	Opaleye Management Inc. Reduces Stake in Harrow Health Inc. (GuruFocus.com)
Aug-11-23 01:05PM	Harrow Health, Inc. (NASDAQ:HROW) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-10-23 09:54AM	Q2 2023 Harrow Health Inc Earnings Call (Thomson Reuters StreetEvents) -15.45%
Aug-09-23 04:14PM	Harrow: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Harrow Announces Second Quarter 2023 Financial Results (Business Wire)
Jul-31-23 07:00AM	Harrow Launches VIGAMOX® in the U.S. (Business Wire)
Jul-28-23 02:56PM	10 Best Small Cap Pharma Stocks to Buy (Insider Monkey)
Jul-26-23 03:42PM	Harrow Health inks deals for the rights to eight medications (American City Business Journals)
09:00AM	Harrow to Announce Second Quarter 2023 Financial Results on August 9, 2023 (Business Wire)

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Opaleye Management Inc.	10% Owner	Jun 10 '25	Sale	30.80	15,000	462,033	90,000	Jun 11 04:15 PM
Opaleye Management Inc.	10% Owner	Jun 09 '25	Sale	30.37	15,204	461,794	105,000	Jun 11 04:15 PM
Opaleye Management Inc.	10% Owner	Jun 03 '25	Sale	30.04	3,000	90,116	122,000	Jun 05 04:05 PM
Opaleye Management Inc.	10% Owner	Jun 04 '25	Sale	30.02	1,796	53,907	120,204	Jun 05 04:05 PM
Opaleye Management Inc.	10% Owner	May 12 '25	Sale	25.90	10,000	258,959	130,000	May 14 04:56 PM
Opaleye Management Inc.	10% Owner	May 13 '25	Sale	26.59	5,000	132,945	125,000	May 14 04:56 PM
BOLL ANDREW R.	Chief Financial Officer	Apr 03 '25	Option Exercise	0.00	346,500	0	914,589	Apr 07 09:55 PM
SAHAREK JOHN P.	CEO & President, ImprimisRx	Apr 03 '25	Option Exercise	0.00	277,200	0	576,863	Apr 07 09:54 PM
BAUM MARK L	Chief Executive Officer	Apr 03 '25	Option Exercise	0.00	762,300	0	2,899,825	Apr 07 09:54 PM
Opaleye Management Inc.	10% Owner	Mar 18 '25	Sale	30.01	5,000	150,055	140,000	Mar 26 04:05 PM
Opaleye Management Inc.	10% Owner	Mar 18 '25	Sale	29.64	5,000	148,200	145,000	Mar 20 04:05 PM
Opaleye Management Inc.	10% Owner	Feb 28 '25	Sale	28.05	5,000	140,250	150,000	Mar 04 04:44 PM
Opaleye Management Inc.	10% Owner	Jan 22 '25	Sale	35.59	20,000	711,814	155,000	Jan 24 09:29 PM
SAHAREK JOHN P.	CEO of ImprimisRx	Sep 11 '24	Option Exercise	7.37	90,000	663,300	344,803	Sep 13 05:26 PM

CHCT

Community Healthcare Trust Inc

HROW

Harrow Inc

Upgrade your FINVIZ experience